Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NTH
|
|||
| Former ID |
DIB014093
|
|||
| Drug Name |
Ruthenium-based complexes
|
|||
| Synonyms |
HC-11; HC-29; ONCO-4400; ONCO-4402; ONCO-4403; ONCO-4417; RM-175; Ruthenium series (cancer), Oncosense; Ruthenium-based complexes (cancer); Ruthenium-based complexes (cancer), MMI; Ruthenium-based complexes (cancer), Oncosense
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Company |
University of Edinburgh
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01463956) Clinical Trial to Evaluate the Efficacy of Pegylated Interferon-Ribavirin-Boceprevir Triple Therapy in Patients Infected With Genotype 1 HCV With Cirrhosis and Awaiting Liver Transplantation (ANRS HC 29 BOCEPRETRANSPLANT). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.